CFAR offered a general Pilot Award program from 1994 to 2017 and funded 82 early stage investigators.
In 2022, CFAR initiated a new program: Pilot Award for Investigators New to HIV.
82 Awards
-
Physicians' Attitudes Toward Assisted Suicide in AIDS: a 5-Year Comparison Study
Physicians' Attitudes Toward Assisted Suicide in AIDS: a 5-Year Comparison Study
Abstract
-
Provision of Extended Nevirapine to Breastfeeding Infants to Reduce Postnatal Transmission of HIV in a Resource-limited Setting: Feasibility, Safety and Effectiveness in a Real world Setting
Provision of Extended Nevirapine to Breastfeeding Infants to Reduce Postnatal Transmission of HIV in a Resource-limited Setting: Feasibility, Safety and Effectiveness in a Real world Setting
Abstract
In recent years the risk of mother-to-child transmission of HIV in developed countries has declined to less than 1%. This success is due to the implementation of a package of interventions including universal HIV screening in pregnancy, provision of highly active antiretroviral therapy (HAART) to HIV-infected pregnant women, antiretroviral (ARV) prophylaxis for the infant during the first 6 weeks of life and avoidance of breastfeeding. In resource-limited countries however, vertical transmission rates can be as high as 35-40% in untreated breastfeeding populations.
-
Sex Differences in Patterns of Migration and HIV Risk in Western Kenya
Sex Differences in Patterns of Migration and HIV Risk in Western Kenya
Abstract
Research on the role of migration in the spread of HIV/AIDS has almost exclusively focused on male labor migration patterns, finding migration to be a risk factor for men and their non-migrant partners, yet neglecting to measure the HIV risks of migration for women. Moreover, the very manner in which migration is conventionally studied is shaped by the paradigm of male labor migration, and thus fails to capture the complexity of women's mobility in sub-Saharan Africa today.
-
Physicians' Attitudes Toward Assisted Suicide in AIDS: a 5-Year Comparison Study
Physicians' Attitudes Toward Assisted Suicide in AIDS: a 5-Year Comparison Study
Abstract
-
Effect of Malaria Chemoprevention on Naturally Acquired T-Cell Mediated Immunity to Malaria
Effect of Malaria Chemoprevention on Naturally Acquired T-Cell Mediated Immunity to Malaria
Abstract
Malaria is the leading cause of morbidity and mortality among children in Uganda. The clinical presentation of malaria is modulated by the natural development of acquired immunity, which develops slowly, wanes rapidly, and is poorly understood. A more thorough understanding of natural immunity to malaria and its development during early childhood is needed to inform development of an effective vaccine.
-
Highly Active Antiretroviral Therapy and Lymphoid Irradiation, with Thymic Shielding, in Subjects with HIV Disease
Highly Active Antiretroviral Therapy and Lymphoid Irradiation, with Thymic Shielding, in Subjects with HIV Disease
Abstract
-
Cohort Study: Study on the Consequences of the Protease-Inhibitor Era (SCOPE)
Cohort Study: Study on the Consequences of the Protease-Inhibitor Era (SCOPE)
Abstract
-
Effect of Malaria Chemoprevention on Naturally Acquired T-Cell Mediated Immunity to Malaria
Effect of Malaria Chemoprevention on Naturally Acquired T-Cell Mediated Immunity to Malaria
Abstract
Malaria is the leading cause of morbidity and mortality among children in Uganda. The clinical presentation of malaria is modulated by the natural development of acquired immunity, which develops slowly, wanes rapidly, and is poorly understood. A more thorough understanding of natural immunity to malaria and its development during early childhood is needed to inform development of an effective vaccine.
-
Highly Active Antiretroviral Therapy and Lymphoid Irradiation, with Thymic Shielding, in Subjects with HIV Disease
Highly Active Antiretroviral Therapy and Lymphoid Irradiation, with Thymic Shielding, in Subjects with HIV Disease
Abstract
-
Cohort Study: Study on the Consequences of the Protease-Inhibitor Era (SCOPE)
Cohort Study: Study on the Consequences of the Protease-Inhibitor Era (SCOPE)
Abstract